Each order of GLP-1/GIP Microdose includes three 2mL vials of GLP-1/GIP and, if clinically appropriate, an additive
PMID: 42 XuXLinLChenPYuYChenSChenXet al
Even if you feel ready, increasing by more than 0.25 mg per step raises your risk of severe side effects
Side effects and safety profile The side effect profile of CagriSema largely reflects what is already known from its two component drugs, with gastrointestinal effects being the most commonly reported
Lee SJ, Lee J, Li KK, Holland D, Maughan H, Guttman DS, et al
FANCL Corporation Japan 3